Prediction of 10-Year Cardiovascular Disease Risk, by Diabetes status and Lipoprotein-a levels; the HellenicSCORE II+ - ScienceDirect

$ 20.50

4.5 (371) In stock

Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review - ScienceDirect

Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk - ScienceDirect

SCORE and SCORE2 in East Asian Population: A Performance Comparison - ScienceDirect

Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region

Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk: A Review for Clinicians - ScienceDirect

IJMS, Free Full-Text

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes - ScienceDirect

Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk - ScienceDirect

Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes - ScienceDirect

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society - ScienceDirect

Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys - ScienceDirect

Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023 - ScienceDirect

Dyslipidaemia in type 2 diabetes: cardiovascular risk assessment and management

The recalibrated HellenicSCORE based on newly derived risk factors from the Hellenic National Nutrition and Health Survey (HNNHS); the HellenicSCORE II - ScienceDirect

SCORE2- diabetes prediction model estimates the 10 year risk of cardiovascular disease in individuals with type 2 diabetes